Skip to main content

Category: Infectious Diseases

  • David Wohl, MD-covid-newsworthy-january-14-20

    Local Health Care Workers Split On Getting COVID Vaccine

    David Wohl, MD Although health care workers are slated to be first to have access to the COVID-19 vaccine, the employees at local hospitals are split when it comes to enthusiasm for getting vaccinated. WRAL interviewed David Wohl, MD, professor of medicine in the division of infectious diseases, who will be one of the first to have access to get the vaccine. He said he’ll happily … Read more

  • Adaora A. Adimora, MD, MPH

    HIVMA Names Adimora 2020 Clinical Educator of the Year

    Adaora A. Adimora, MD, MPH The HIV Medicine Association, or HIVMA, honored UNC infectious diseases professor Ada Adimora, MD, MPH, with its 2020 Clinical Educator Award. The award, presented during the annual IDWeek conference, recognizes Adimora’s “extraordinary contributions to advancing clinical education, with a focus on disseminating her research on the drivers of HIV-relate … Read more

  • emily-ciccone

    Ciccone Wins Clinical Research Award From ASTMH

    Ciccone (far right) in Uganda with MUST/UNC staff in front of the Kasese Health Centre. Emily Ciccone, MD, MHS, infectious diseases fellow and pediatric medicine instructor, recently won first prize in the clinical research award session of the 2020 annual meeting of the American Society of Tropical Medicine and Hygiene. The award recognizes excellence in clinical research by you … Read more

  • covid-testing-team

    NIH Funds Study Aimed at Improving Access to COVID-19 Testing for Underserved NC communities

    UNC mobile COVID-19 testing team including David Wohl, MD, far left, and Michael Herce, MD, far right. A team of investigators from UNC’s Institute for Global Health and Infectious Diseases has been awarded $1.5 million from the National Institutes of Health to conduct a two-year implementation science study to scale up COVID-19 testing in North Carolina. “We want to improve acce … Read more

  • Myron Cohen, MD, and Joe Eron, MD

    NIH Awards Seven-Year Funding to HIV Prevention Trials Network, AIDS Clinical Trials Group Also Re-funded For Seven-Year Study

    Myron Cohen, MD, and Joe Eron, MD Myron S. Cohen, MD, director of UNC’s Institute for Global Health and Infectious Diseases, and Wafaa El-Sadr, MD, MPH, MPA, director of ICAP at Columbia University, have received a seven-year award from the National Institutes of Health for leadership of the HIV Prevention Trials Network (HPTN) in collaboration with FHI 360. The first year of sup … Read more

  • eron-hosseinipour-wohl

    NIH Awards $25 Million to UNC’s Global HIV Clinical Trials Unit

    Joe Eron, MD, Mina Hosseinipour, MD, and David Wohl, MD The National Institutes of Health has awarded University of North Carolina’s Institute for Global Health & Infectious Diseases nearly $25 million over seven years to continue operating its Global HIV Clinical Trials Unit, or CTU. The new funding will support HIV treatment and prevention in adults, children and pregnant w … Read more

  • Myron Cohen, MD-ID-faculty-in-covid-news-dec-24-30

    Cohen Says This Will Be a Difficult Winter

    Myron Cohen, MD WTVD-11 News reports how the UK’s approval of the Pfizer vaccine could benefit North Carolina and asks who will get the vaccine first. Myron Cohen, MD, the Yeargan-Bate Distinguished Professor of Medicine in the division of infectious diseases, tells WTVD-11 that the coming winter will be difficult. “I think everybody is forewarning that the spike increase in case … Read more

  • CindyGay-newsworthy-nov-2021

    COVID Vaccine Trial Update

    Cindy Gay, MD, MPH Charlotte’s WBTV News interviewed Cindy Gay, MD, MPH, associate professor of medicine in the division of infectious diseases, for an update on the COVID vaccine trials. Gay shared her enthusiasm and confidence in the latest data. Watch the interview here.

  • Doctors Provide Up-Close View of Pandemic in Area Hospitals, Guidance On Limiting Viral Spread

    David Wohl, MD, talked about the pandemic with other infectious disease experts on WRAL. Infectious disease experts David Wohl, MD, Cameron Wolfe, MBBS (Duke University Health), and Chris DeRienzo, MD, MPP (WakeMed), discuss what they’re seeing at area hospitals during the pandemic and ways to slow the surge in new coronavirus infections. See this 30-minute round-table Zoom discu … Read more

  • david-wohl-tarheel-of-the-month

    Wohl Named Tar Heel of the Month

    David Wohl, MD (credit: Mark Derewicz) For his years of work studying infectious diseases and his role in helping North Carolina health professionals and residents respond to the pandemic, David Wohl, MD, is the News & Observer’s November Tar Heel of the Month, which honors people who have made significant contributions to North Carolina and the region.  Read the story in the … Read more

  • Wohl Honored With First Charles Van Der Horst Humanitarian Award

    David Wohl, left, takes a break while cycling with his former colleague and mentor, Charlie van der Horst (credit: UNC IGHID) The national AIDS Clinical Trials Group expanded its annual recognition program in 2020 with two new awards named for University of North Carolina faculty members who died in 2019: Charles van der Horst, MD, an infectious diseases physician and researcher, … Read more

  • Joe Eron, MD

    More COVID-19 Vaccine Options Could Aid Distribution Timeline, Especially in Rural Areas

    Joe Eron, MD News of Oxford University and AstraZeneca’s successful COVID-19 vaccine trial is inspiring increased optimism within the medical community. “We need billions of doses. And different vaccines have different upsides and downsides. Like the newest one we heard about yesterday, AstraZeneca. It’s easier to manufacture. So there (are) more doses that can be made, and proba … Read more